Stay updated on Semaglutide Once-weekly vs Placebo add-on to SGLT-2i in T2DM Clinical Trial

Sign up to get notified when there's something new on the Semaglutide Once-weekly vs Placebo add-on to SGLT-2i in T2DM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Semaglutide Once-weekly vs Placebo add-on to SGLT-2i in T2DM Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Added revision tag v3.5.4 and removed v3.5.3, indicating an update to the page's underlying revision/version.
    Difference
    0.0%
    Check dated 2026-05-15T23:54:51.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page footer revision was updated from “Revision: v3.5.0” to “Revision: v3.5.3,” reflecting a ClinicalTrials.gov site/version release rather than any change to the study information.
    Difference
    0.0%
    Check dated 2026-04-24T16:40:26.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    - Added Revision: v3.5.0 and removed Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-19T19:47:25.000Z thumbnail image
  6. Check
    98 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-12T02:34:28.000Z thumbnail image
  7. Check
    105 days ago
    Change Detected
    Summary
    The only change observed is a revision update on the page from v3.4.0 to v3.4.1, with no alteration to study details, eligibility criteria, outcomes, locations or other user-visible content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T00:26:17.000Z thumbnail image
  8. Check
    112 days ago
    Change Detected
    Summary
    Glossary display is now shown and new metadata items were added: 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0', while the previous items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-28T22:15:53.000Z thumbnail image

Stay in the know with updates to Semaglutide Once-weekly vs Placebo add-on to SGLT-2i in T2DM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Semaglutide Once-weekly vs Placebo add-on to SGLT-2i in T2DM Clinical Trial page.